Analysis and Discussion of Common Problems in the Pre-approval Inspection of Heparin Drugs

HU Xiaojuan

PDF(2202 KB)
主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
PDF(2202 KB)
Chinese Journal of Pharmaceuticals ›› 2023, Vol. 54 ›› Issue (04) : 617-621. DOI: 10.16522/j.cnki.cjph.2023.04.020
Pharmaceutical Management & Information

Analysis and Discussion of Common Problems in the Pre-approval Inspection of Heparin Drugs

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 54(04): 617-621 https://doi.org/10.16522/j.cnki.cjph.2023.04.020

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2202 KB)

Accesses

Citation

Detail

Sections
Recommended

/